Table 3.

Cumulative clinical events following hybrid strategy.

	Patients, n = 109
Procedural success	106 (97.2)
Procedural success with QFR value more than 0.8 in all treated vessels	105 (96.3)
In‐hospital events
Cardiac death	0 (0.0)
Periprocedural MI	6 (5.5)
ST (definite/probable)	0 (0.0)
Follow‐up events
Cardiac death	0 (0.0)
TVR	6 (5.5)
Spontaneous MI	3 (2.8)
MACE	13 (11.9)
MACE excluding periprocedural MI	7 (6.4)
ST (definite/probable)	2 (1.8)
TLR	3 (2.8)

Note: Values are presented as n (%). MACE is defined as cardiac death, MI (including peri‐procedural MI) and TVR.

Abbreviations: MACE, major adverse cardiac events; MI, myocardial infarction; QFR, quantitative flow ratio; ST, stent thrombosis; TLR, target lesion revascularization; TVR, target vessel revascularization.